Cargando…
PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
The peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-activated transcriptional factor that belongs to the nuclear hormone receptor superfamily. PPARγ was initially identified through its role in the regulation of glucose and lipid metabolism and cell differentiation. It also infl...
Autores principales: | Corona, Juan Carlos, Duchen, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326663/ https://www.ncbi.nlm.nih.gov/pubmed/25007880 http://dx.doi.org/10.1007/s11064-014-1377-0 |
Ejemplares similares
-
PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
por: Corona, Juan Carlos, et al.
Publicado: (2016) -
Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia
por: Shibata, Nobuto, et al.
Publicado: (2013) -
On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis
por: Hacksell, Uli, et al.
Publicado: (2014) -
PGC-1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS Production
por: Wang, Chaoqun, et al.
Publicado: (2021) -
Design and Development
of Novel Glitazones for Activation
of PGC-1α Signaling Via PPAR-γ Agonism: A Promising
Therapeutic Approach against Parkinson’s Disease
por: Prabhakaran, Prabitha, et al.
Publicado: (2023)